P0865 : The use of sofosbuvir based regimens amongst treatment naive and experienced patients with advanced fibrosis/cirrhosis: Real world results from a difficult to treat cohort

MLA

Ray Fox, et al. “P0865 : The Use of Sofosbuvir Based Regimens amongst Treatment Naive and Experienced Patients with Advanced Fibrosis/Cirrhosis: Real World Results from a Difficult to Treat Cohort.” Journal of Hepatology, vol. 62, Apr. 2015, pp. S664–65. EBSCOhost, https://doi.org/10.1016/s0168-8278(15)31067-9.

APA

Ray Fox, J. Morris, Stephen T. Barclay, S. Datta, M. Priest, D. Sutherland, M. Heydtmann, Adrian J. Stanley, Peter R. Mills, & Ewan Forrest. (2015). P0865 : The use of sofosbuvir based regimens amongst treatment naive and experienced patients with advanced fibrosis/cirrhosis: Real world results from a difficult to treat cohort. Journal of Hepatology, 62, S664–S665. https://doi.org/10.1016/s0168-8278(15)31067-9

Chicago

Ray Fox, J. Morris, Stephen T. Barclay, S. Datta, M. Priest, D. Sutherland, M. Heydtmann, Adrian J. Stanley, Peter R. Mills, and Ewan Forrest. 2015. “P0865 : The Use of Sofosbuvir Based Regimens amongst Treatment Naive and Experienced Patients with Advanced Fibrosis/Cirrhosis: Real World Results from a Difficult to Treat Cohort.” Journal of Hepatology 62 (April): S664–65. doi:10.1016/s0168-8278(15)31067-9.